33 results
8-K
EX-99.1
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
the Centers for Disease Control and Prevention. PEMGARDA targets the SARS-CoV-2 spike protein receptor binding domain (RBD), thereby inhibiting virus
8-K
EX-99.1
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
Control and Prevention. PEMGARDA targets the SARS-CoV-2 spike protein receptor binding domain (RBD), thereby inhibiting virus attachment to the human
8-K
EX-99.1
1r1u3vtw
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
EX-99.1
r8wk767yi52q1sa
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
1w3o1lo0
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
DEFC14A
euzbjfkk66
29 Apr 22
Proxy in contested solicitation
4:02pm
PRRN14A
s503nzsipng89tvb
27 Apr 22
Revised preliminary proxy statement filed by non-management
1:13pm
PRRN14A
j3nn45ehf7 ghiqy
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
PREC14A
foal0v
11 Apr 22
Preliminary proxy with contested solicitation
6:44am